CK Life Sciences Int'l. (Holdings) Inc

F:LSI Germany Biotechnology
Market Cap
$804.04 Million
€783.30 Million EUR
Market Cap Rank
#15014 Global
#1547 in Germany
Share Price
€0.08
Change (1 day)
-5.78%
52-Week Range
€0.05 - €0.11
All Time High
€0.11
About

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; m… Read more

CK Life Sciences Int'l. (Holdings) Inc - Asset Resilience Ratio

Latest as of June 2025: 0.06%

CK Life Sciences Int'l. (Holdings) Inc (LSI) has an Asset Resilience Ratio of 0.06% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€6.74 Million
Cash + Short-term Investments
Total Assets
€11.29 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how CK Life Sciences Int'l. (Holdings) Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down CK Life Sciences Int'l. (Holdings) Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €6.74 Million 0.06%
Total Liquid Assets €6.74 Million 0.06%

Asset Resilience Insights

  • Limited Liquidity: CK Life Sciences Int'l. (Holdings) Inc maintains only 0.06% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

CK Life Sciences Int'l. (Holdings) Inc Industry Peers by Asset Resilience Ratio

Compare CK Life Sciences Int'l. (Holdings) Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Halozyme Therapeutics Inc
NASDAQ:HALO
Biotechnology 12.71%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
ESSA Pharma Inc
NASDAQ:EPIX
Biotechnology 21.42%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%

Annual Asset Resilience Ratio for CK Life Sciences Int'l. (Holdings) Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for CK Life Sciences Int'l. (Holdings) Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.16% €17.24 Million €10.79 Billion +0.05pp
2023-12-31 0.11% €11.84 Million €11.25 Billion 0.00pp
2022-12-31 0.11% €12.19 Million €11.27 Billion +0.01pp
2021-12-31 0.10% €11.67 Million €11.73 Billion -0.01pp
2020-12-31 0.11% €12.71 Million €11.98 Billion -0.05pp
2019-12-31 0.16% €16.64 Million €10.71 Billion +0.04pp
2018-12-31 0.11% €11.59 Million €10.44 Billion -0.04pp
2017-12-31 0.15% €16.36 Million €10.58 Billion -0.04pp
2016-12-31 0.19% €18.09 Million €9.54 Billion --
pp = percentage points